Genelink, Inc. (GNLKQ)

[marimar]

To support its vision, GeneLink has developed an impressive portfolio of DNA-based assessments and proprietary systems for individually tailored product manufacture and delivery. Each (patented or patent pending) GeneLink "panel" design is based on a carefully selected set of SNPs associated with a particular physiologic condition or imbalance such as cardiovascular health, oxidative stress, bone metabolism, etc. To enable this, Genelink has created the only patented, FDA reviewed, non-invasive, self-administered DNA collection system available today (US patent 6,291,171). The process starts when a person simply swabs the inside of their mouth (inner cheek) and mails the swabs back to GeneLink's laboratories.